Provided by Tiger Fintech (Singapore) Pte. Ltd.

Avalo Therapeutics Inc

4.78
+0.02000.42%
Post-market: 5.010.2300+4.81%18:09 EDT
Volume:93.80K
Turnover:443.78K
Market Cap:51.76M
PE:-0.97
High:4.85
Open:4.78
Low:4.55
Close:4.76
Loading ...
Jun 28, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Jun 26, 2023

Major Issues Report

Form 8-K - Current report
Jun 02, 2023

Major Issues Report

Form 8-K - Current report
May 04, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
May 04, 2023

Major Issues Report

8-K - Current report
May 04, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 04, 2023

Major Issues Report

8-K - Current report
Apr 28, 2023

Correspondence

Form CORRESP - Correspondence
Apr 21, 2023

Major Issues Report

8-K - Current report
Mar 29, 2023

Major Issues Report

8-K - Current report
Mar 29, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 13, 2023

Major Issues Report

8-K - Current report
Feb 17, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 13, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2023

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Feb 03, 2023

Major Issues Report

8-K - Current report
Jan 17, 2023

Major Issues Report

8-K - Current report
Nov 14, 2022

Major Issues Report

8-K - Current report